Search alternatives:
material » materials (Expand Search)
Showing 521 - 540 results of 2,756 for search 'material dysfunction', query time: 0.10s Refine Results
  1. 521

    Comparative efficacy of amiodarone with ivabradin combination or amiodarone with bisoprolol combination in the prevention of atrial fibrillation recurrence in pa- tients with left... by K. G. Adamyan, L. G. Tunyan, A. L. Chilingaryan

    Published 2015-11-01
    “…To study the efficacy of use of amiodarone with ivabradine combination or amiodarone with bisoprolol combination in the prevention of atrial fibrillation (AF) recurrence in patients (pts) with left ventricular diastolic dysfunction (LVDD) after conversion to sinus rhythm. …”
    Get full text
    Article
  2. 522

    CARDIAC MAGNETIC RESONANCE IMAGING AND POSITRON EMISSION TOMOGRAPHY IN THE PREDICTION OF LEFT VENTRICULAR DYSFUNCTION REVERSIBILITY IN PATIENTS WITH CHRONIC TOTALLY OCCLUDED CORONA... by D. V. Ryzhkova, I. S. Kostina

    Published 2014-02-01
    “…Material and methods. The study included 26 patients with chronic coronary heart disease and angiographically confirmed CTO CA. …”
    Get full text
    Article
  3. 523

    Single-Photon Emission Computed Tomography in the Diagnosis of Early Postoperative Cognitive Dysfunction After Combined Carotid Endarterectomy and Coronary Artery Bypass Grafting by O. V. Maleva, A. A. Korotkevich, O. A. Trubnikova, S. E. Semenov, O. L. Barbarash

    Published 2024-01-01
    “…Objective: to study the contribution of regional cerebral blood flow (rCBF) indicators to the diagnosis of early postoperative cognitive dysfunction (POCD) in patients with multifocal atherosclerosis (MFA) with heart and brain revascularization.Material and methods. …”
    Get full text
    Article
  4. 524

    Comparative study of yogic practices and dietary modifications on biochemical variables among middle-aged women on metabolic dysfunction – Associated steatotic liver disease by S. Selva Sundari, C. V. Jayanthy, S. Natarajan

    Published 2025-06-01
    “… Background and Aim of Study: Non-Alcoholic Fatty Liver Disease (NAFLD), now more broadly termed Metabolic Dysfunction – Associated Steatotic Liver Disease (MAFLD), poses a significant health risk for women, particularly in India where its prevalence ranges from 9.0% to 53.0%, with middle-aged women comprising 29.1% of those affected. …”
    Get full text
    Article
  5. 525
  6. 526

    Associations of NT-proBNP and hepcidin levels with clinical and laboratory parameters in patients with heart failure with various severity of left ventricular systolic dysfunction by V. I. Podzolkov, N. A. Dragomiretskaya, S. K. Stolbova, I. S. Rusinov

    Published 2020-09-01
    “…To identify the association of NT-proBNP and hepcidin levels with clinical and laboratory parameters in patients with HF with various severity of left ventricular (LV) systolic dysfunction.Material and methods. The study included 68 patients (29 women, 39 men; mean age — 72,3±11,7 years) hospitalized due to decompensated HF. …”
    Get full text
    Article
  7. 527

    EFFECT OF «TREAT-TO-TARGET» ANTIRHEUMATIC THERAPY ON DIASTOLIC DYSFUNCTION OF THE LEFT AND RIGHT VENTRICLES IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS DURING 18 MONTHS OF OBSERVAT... by I. G. Kirillova, D. S. Novikova, T. V. Popkova, Yu. N. Gorbunova, E. I. Markelova, Yu. O. Korsakova, O. A. Fomicheva, A. V. Volkov, E. L. Luchikhina, N. V. Demidova, K. A. Kasumova, S. A. Vladimirov, M. A. Kanonirova, G. L. Lukina, A. A. Novikov, E. N. Aleksandrova, D. E. Karateev, E. L. Nasonov

    Published 2015-09-01
    “…To study the effect of «treat-to-target» antirheumatic therapy on diastolic dysfunction of the left (DDLV) and right (DDLV) ventricles in patients with early rheumatoid arthritis (RA) during 18 months of observation.Material and methods. …”
    Get full text
    Article
  8. 528
  9. 529

    Revisiting the causal impact of lipid traits on metabolic dysfunction‐associated fatty liver disease: Insights from a multidimensional plasma lipid profile by Fang Xie, Wenkai Zheng, Jing Chen, Chuanxia Yao, Cong Li, Li Tang, Ping Li, Shanzhong Tan

    Published 2025-05-01
    “…ABSTRACT Aims Recent advancements in plasma lipidomes genome‐wide association studies data have enhanced our understanding of lipid categories, significantly improving risk assessments for metabolic dysfunction‐associated fatty liver disease (MAFLD) beyond traditional lipid biomarkers. …”
    Get full text
    Article
  10. 530

    COVID-19 infection may reduce serum testosterone levels and increase the risk of erectile dysfunction: A two-sample Mendelian randomization study by Ting Wang, Chao Li, Jinbo Song

    Published 2025-03-01
    “…This study aims to provide evidence for the causal relationship between COVID-19 infection, serum testosterone levels and the risk of erectile dysfunction (ED) using a two-sample Mendelian randomization (MR) approach. …”
    Get full text
    Article
  11. 531

    Acute-on-chronic liver failure due to hepatitis A infection in a patient with Metabolic Dysfunction- Associated Fatty Liver Disease. Case report. by Omar Ocampo-Espinosa, Mariana Jacinto-Ruiz

    Published 2025-04-01
    “…Introduction and Objectives: Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) has steadily increased its prevalence, making it the most common liver disease in Western industrialized nations, affecting one billion people worldwide. …”
    Get full text
    Article
  12. 532

    Metabolic dysfunction‐associated steatotic liver disease: A superior predictor for incident type 2 diabetes over traditional criteria – NAGALA study by Kimiko Sakai, Takuro Okamura, Ema Toyokuni, Hiroshi Okada, Akihiro Obora, Takao Kojima, Masahide Hamaguchi, Michiaki Fukui

    Published 2024-12-01
    “…ABSTRACT Aims/Introduction The 2023 Delphi consensus recommended the use of new term, metabolic dysfunction‐associated steatotic liver disease (MASLD), aiming conceptual shift from the conventional non‐alcoholic fatty liver disease (NAFLD). …”
    Get full text
    Article
  13. 533

    Angiopoietin-1 as a marker of endothelial dysfunction and a risk factor for acute kidney injury in patients with COVID-19: retrospective cohort study by A. A. Schepalina, N. V. Chebotareva, L. A. Akulkina, M. Yu. Brovko, V. I. Sholomova, P. P. Potapov, D. S. Valiulina, S. V. Moiseev

    Published 2022-11-01
    “…To define the role of angiopoetin-1(Ang-1) as a marker of endothelial dysfunction in development of AKI in patients, hospitalized with COVID-19.Materials and methods. 76 patients with confirmed coronavirus infection were included in the study. …”
    Get full text
    Article
  14. 534
  15. 535
  16. 536

    Effect of Alternate day fasting over Metabolic dysfunction-associated steatohepatitis in adult offspring of dams exposed to cafeteria diet during pregnancy and lactation. by Martín G. García-Juárez, Tania G. Heredia-Torres, Daniel Arellanos-Soto, Blanca E. Álvarez-Salas, Alberto Camacho-Morales, Ana María G. Rivas-Estilla

    Published 2025-04-01
    “…Introductions and Objectives: Metabolic dysfunction-associated steatohepatitis (MASH) is a liver disease characterized by lipid accumulation and inflammation that can be exacerbated by cafeteria diets (CAF) exposition during pregnancy and lactation, whereas Alternate day fasting (ADF) improves metabolic parameters. …”
    Get full text
    Article
  17. 537
  18. 538

    Peptides of Laennec® preparation that contribute to the elimination of endotheliopathy by I. Yu. Torshin, О. А. Gromova, V. G. Zgoda, А. G. Chuchalin, V. А. Maksimov, О. V. Tikhonova

    Published 2022-01-01
    “…Objective: identification of peptides in the composition of Laennec®, which can inhibit the development of endotheliopathy (endothelial dysfunction).Material and methods. Hybrid mass spectrometry followed by data analysis based on topological recognition theory was performed. …”
    Get full text
    Article
  19. 539
  20. 540